tetrahydrocurcumin has been researched along with tacrolimus in 2 studies
| Studies (tetrahydrocurcumin) | Trials (tetrahydrocurcumin) | Recent Studies (post-2010) (tetrahydrocurcumin) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 170 | 4 | 112 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | tetrahydrocurcumin (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, HJ; Kim, HJ; Lee, JH; Oh, MY; Park, CS | 1 |
| Arora, C; Chitkara, D; Kakkar, V; Saini, K; Saini, M; Sharma, S | 1 |
2 other study(ies) available for tetrahydrocurcumin and tacrolimus
| Article | Year |
|---|---|
Tetrahydrocurcumin Ameliorates Tacrolimus-Induced Nephrotoxicity Via Inhibiting Apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Curcumin; Immunosuppressive Agents; Kidney; LLC-PK1 Cells; Oxidative Stress; Swine; Tacrolimus | 2018 |
Preclinical safety of tetrahydrocurcumin loaded lipidic nanoparticles incorporated into tacrolimus ointment: In vitro and in vivo evaluation.
Topics: Animals; Curcumin; Mice; Mice, Inbred BALB C; Nanoparticles; Ointments; Psoriasis; Rats; Tacrolimus | 2022 |